No abstract available
MeSH terms
-
Animals
-
Antineoplastic Agents / therapeutic use
-
Benzamides
-
Combined Modality Therapy
-
Hematologic Neoplasms / immunology*
-
Hematologic Neoplasms / therapy*
-
Humans
-
Imatinib Mesylate
-
Immunity, Innate
-
Immunotherapy / methods*
-
Immunotherapy / trends
-
Killer Cells, Natural / immunology*
-
Lymphocyte Activation
-
Piperazines / therapeutic use
-
Pyrimidines / therapeutic use
-
T-Lymphocyte Subsets / immunology*
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate